AZD2423
Sponsors
AstraZeneca
Conditions
Chronic Obstructive Pulmonary DiseaseHealthyHealthy VolunteerHealthy VolunteersLung DiseaseNerve PainNeuropathic PainNeuroscience
Phase 1
Study to Investigate Safety, Tolerability and Pharmacokinetics of AZD2423 in Healthy Volunteers
CompletedNCT00940212
Start: 2009-07-31End: 2009-11-30Updated: 2010-12-10
AZD2423 Single Ascending Dose Study in Healthy Japanese Subjects
CompletedNCT00970775
Start: 2009-08-31End: 2009-12-31Updated: 2010-03-18
Study to Investigate Safety, Tolerability and Pharmacokinetics of AZD2423 Multiple Doses in Healthy Japanese Volunteers
CompletedNCT01233830
Start: 2010-11-30End: 2011-03-31Updated: 2011-04-12
Phase 2
Investigation of the Effect of Oral Treatment With 100 mg AZD2423 in Subjects With Mild Chronic Obstructive Pulmonary Disease (COPD)
CompletedNCT01153321
Start: 2010-10-31End: 2011-07-31Updated: 2015-04-10
A Study to Investigate the Analgesic Efficacy of AZD2423 Compared With Placebo After 28 Days Treatment in Patients With Posttraumatic Neuralgia..
CompletedNCT01200524
Start: 2010-10-31End: 2012-04-30Updated: 2014-04-25
A Study to Investigate the Analgesic Efficacy of AZD2423 Compared With Placebo After 28 Days Treatment in Patients With Painful Diabetic Polyneuropathy
CompletedNCT01201317
Start: 2010-09-30End: 2011-06-30Updated: 2014-04-25
AZD2423 Safety and Tolerability Study in Patients With Moderate and Severe Chronic Obstructive Pulmonary Disease(COPD)
CompletedNCT01215279
Start: 2010-10-31End: 2011-03-31Updated: 2014-10-23